Evidence map›Paper›PMID 40691368›Full record

ArticleNature medicine2025

Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial.

Neal D Shore, Thomas B Powles, Jens Bedke, Matthew D Galsky, Joan Palou Redorta, Ja Hyeon Ku, Michal Kretkowski, Evanguelos Xylinas, Boris Alekseev, Dingwei Ye and 11 more

Abstract readPublished Erratum
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advances in the management of localized bladder cancers.Nature reviews. Clinical oncology · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Neal D ShoreSTART Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC, USA. nshore@auclinics.com.ORCID http://orcid.org/0000-0001-5767-0548
Thomas B PowlesBarts Health Biomedical NIHR Research Centre, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0001-7760-4724
Jens BedkeDepartment of Urology & Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany.
Matthew D GalskyThe Tisch Cancer Institute, Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-7655-9378
Joan Palou RedortaDepartment of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-1264-5327
Ja Hyeon KuDepartment of Urology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-0391-2342
Michal KretkowskiClinical Research Center, Spolka z Ograniczona, Poznań, Poland.
Evanguelos XylinasDepartment of Urology, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris Cité, Paris, France.
Boris AlekseevP. Hertsen Moscow Cancer Research Institute, Moscow, Russia.
Dingwei YeFudan University Shanghai Cancer Center, Shanghai, China.ORCID http://orcid.org/0000-0003-4974-3780
Félix Guerrero-RamosDepartment of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0002-0767-3465
Alberto BrigantiDivision of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Girish S KulkarniDivision of Urology, Department of Surgery, Princess Margaret Cancer, Center University of Toronto, Toronto, ON, Canada.
Julia BrinkmannPfizer Pharma GmbH, Berlin, Germany.
Anna-Maria CalellaPfizer SRL, Rome, Italy.
Rossano CesariPfizer SRL, Milan, Italy.
Anthony EcclestonPfizer Ltd., Tadworth, UK.
Elisabete MichelonPfizer Inc., New York, NY, USA.
Jennifer VermettePfizer Inc., Cambridge, MA, USA.ORCID http://orcid.org/0009-0000-8729-8652
Caimiao WeiPfizer Inc., Groton, CT, USA.
Gary D SteinbergDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40691368
PMCPMC12353840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.